Update on the First Year of COVID-19
The current outbreak of the Coronavirus, severe acute respiratory syndrome Coronavirus-2, which originated in the Wuhan province of the People’s Republic of China became a pandemic. Although the clinical findings of the infection vary in adults, the most common symptoms are fever, dry cough, and shortness of breath. The diagnosis of the Coronavirus disease-2019 (COVID-19) is made by clinical symptoms, laboratory tests, and radiological methods. Many drugs such as antivirals, antibiotics, and corticosteroids are used in the treatment of COVID-19. For the successful control of the pandemic, prevention strategies are the key. There is strong consensus that, in addition to wearing masks, hand hygiene, and social distancing, an effective COVID-19 vaccine is probably the most effective approach to sustainably control the pandemic. In this article, current information about the pathogenesis, epidemiology, risk groups, diagnosis, treatment, prevention strategies, and vaccination of the disease in the first year of the COVID-19 pandemic are discussed..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Mediterranean Journal of Infection, Microbes and Antimicrobials - 10(2021), 1 |
| Sprache: |
Türkisch |
|---|
| Beteiligte Personen: |
Elmas Pınar KAHRAMAN KILBAŞ [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Covid-19 |
|---|
| doi: |
10.4274/mjima.galenos.2021.2021.44 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ080392539 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ080392539 | ||
| 003 | DE-627 | ||
| 005 | 20230310190347.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230310s2021 xx |||||o 00| ||tur c | ||
| 024 | 7 | |a 10.4274/mjima.galenos.2021.2021.44 |2 doi | |
| 035 | |a (DE-627)DOAJ080392539 | ||
| 035 | |a (DE-599)DOAJb2ee1cb6303347478eab247e0346e116 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a tur | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Elmas Pınar KAHRAMAN KILBAŞ |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Update on the First Year of COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The current outbreak of the Coronavirus, severe acute respiratory syndrome Coronavirus-2, which originated in the Wuhan province of the People’s Republic of China became a pandemic. Although the clinical findings of the infection vary in adults, the most common symptoms are fever, dry cough, and shortness of breath. The diagnosis of the Coronavirus disease-2019 (COVID-19) is made by clinical symptoms, laboratory tests, and radiological methods. Many drugs such as antivirals, antibiotics, and corticosteroids are used in the treatment of COVID-19. For the successful control of the pandemic, prevention strategies are the key. There is strong consensus that, in addition to wearing masks, hand hygiene, and social distancing, an effective COVID-19 vaccine is probably the most effective approach to sustainably control the pandemic. In this article, current information about the pathogenesis, epidemiology, risk groups, diagnosis, treatment, prevention strategies, and vaccination of the disease in the first year of the COVID-19 pandemic are discussed. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a sars‐cov‐2 | |
| 650 | 4 | |a pandemic | |
| 650 | 4 | |a vaccine | |
| 650 | 4 | |a prevention | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Mustafa ALTINDİŞ |e verfasserin |4 aut | |
| 700 | 0 | |a Kaan YILANCIOĞLU |e verfasserin |4 aut | |
| 700 | 0 | |a İshak Özel TEKİN |e verfasserin |4 aut | |
| 700 | 0 | |a Duran BURAN |e verfasserin |4 aut | |
| 700 | 0 | |a Seçil ÖZKAN |e verfasserin |4 aut | |
| 700 | 0 | |a Alper ŞENER |e verfasserin |4 aut | |
| 700 | 0 | |a Mustafa Necmi İLHAN |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Mediterranean Journal of Infection, Microbes and Antimicrobials |d Galenos Yayinevi, 2017 |g 10(2021), 1 |w (DE-627)DOAJ000019046 |x 2147673X |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:1 |
| 856 | 4 | 0 | |u https://doi.org/10.4274/mjima.galenos.2021.2021.44 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/b2ee1cb6303347478eab247e0346e116 |z kostenfrei |
| 856 | 4 | 0 | |u http://mjima.org/abstract.php?id=268 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2147-673X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |e 1 | ||